The Wheelchair Manufacturing industry experienced a steady decline over the five years to 2017. Although key trends in the healthcare sector have been positive in recent years, domestic manufacturing of wheelchairs has fallen. The number of adults aged 65 and older, the largest downstream user of wheelchairs, has steadily increased over the five years. Moreover, Medicaid and Medicare spending, as well as the number of people with private health insurance, have steadily grown. This has generated an overall increase in total healthcare expenditures, which has supported more purchases of healthcare related equipment. Nonetheless, industry revenue has declined as regulations surrounding Medicaid reimbursement shifted and a key industry operator experienced issues with Food and Drug Administration (FDA) compliance. Over the five years to 2022, the industry is expected to recover. The population will continue to age, bolstering demand for medical care and long-term durable medical equipment, such as wheelchairs. While potential changes to healthcare regulations pose a risk to Medicaid spending, Medicare is the primary coverage for the elderly who demand the bulk of industry product. Moreover, Invacare is expected to resume production in 2017, which should present a boon to the industry's domestic manufacturing level.
Operators in this industry manufacture manual and powered wheelchairs and powered scooters.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.